Oncology & Cancer

Intralesional IL-2 promising for cutaneous melanoma metastases

(HealthDay)—Patients with cutaneous melanoma metastases have excellent response to intralesional interleukin 2 (IL-2) administered concomitantly with topical imiquimod and a retinoid cream, according to a case series published ...

page 2 from 2